СТРАТЕГИИ ЛЕЧЕНИЯ САХАРНОГО ДИАБЕТА ПЕРВОГО ТИПА НА ЭТАПЕ ПРЕКОНЦЕПЦИОННОЙ ПОДГОТОВКИ, ВО ВРЕМЯ БЕРЕМЕННОСТИ И РОДОВ


Мищенко О.И., Елгина С.И., Мозес К.Б., Мозес В.Г., Рудаева Е.В.

Аннотация


Цель исследования – провести аналитический обзор современных источников научной литературы, освещающих вопросы лечения сахарного диабета первого типа на этапе планирования беременности, во время беременности и после родов.

Материалы и методы. Проведен анализ 56 отечественных и зарубежных источников литературы по данной теме.

Результаты. По результатам анализа научных данных обновлено представление о лечении сахарного диабета первого типа до и во время беременности.

Заключение. Сахарный диабет первого типа ассоциирован с неблагоприятными исходами для матери и плода, однако своевременная преконцепционная подготовка и терапия во время беременности позволяет снизить эти риски.


Ключевые слова


сахарный диабет первого типа; преконцепционная подготовка; лечение

Полный текст:

Full Text PDF Full Text HTML

Литература


Cohen AL, Wenger JB, James-Todd T, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014; 33(1): 81-92. doi: 10.3109/10641955.2013.837175

Wahabi H, Alzeidan R, Bawazeer G, Alansari L, Esmaeil S. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010; 10: 63. doi: 10.1186/1471-2393-10-63

Garg S, Ampudia-Blasco FJ, Pfohl M. Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus. Endocr Pract. 2010; 16(3): 486-505. doi: 10.4158/EP09294.RA

Ranasinghe PD, Maruthur NM, Nicholson WK, et al. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt). 2015; 24(3): 237-249. doi: 10.1089/jwh.2014.4939

Tennagels N, Werner U. The metabolic and mitogenic properties of basal insulin analogues. Arch Physiol Biochem. 2013; 119(1): 1-14. doi: 10.3109/13813455.2012.754474

Pollex E, Moretti ME, Koren G, Feig DS. Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother. 2011; 45: 9-16. doi: 10.1345/aph.1P327

Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Brøndsted L, Jovanovic L, et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012; 35(10): 2012-2017. doi: 10.2337/dc11-2264

Hod M, Mathiesen ER, Jovanovič L, McCance DR, Ivanisevic M, Durán-Garcia S, et al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med. 2014; 27(1): 7-13. doi: 10.3109/14767058.2013.799650

Valk HW, Visser GH. Insulin during pregnancy, labour and delivery. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 65-76. doi: 10.1016/j.bpobgyn.2010.10.002

James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. 2014; 311(5): 507-520. doi: 10.1001/jama.2013.284427

Elgina SI, Kondratova LA. Outcomes of pregnancy and childbirth in young people. Mother and Baby in Kuzbass. 2020; 3: 30-34. Russian (Елгина С.И., Кондратова Л.А. Исходы беременности и родов у юных //Мать и Дитя в Кузбассе. 2020. № 3. С. 30-34)

Li DK, Yang C, Andrade S, Tavares V, Ferber JR. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ. 2011; 343: d5931. doi: 10.1136/bmj.d5931

Diav-Citrin O, Shechtman S, Halberstadt Y, et al. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol. 2011; 31: 540-545. doi: 10.1016/j.reprotox.2011.02.008

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, et al. Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials. Diabetologia. 2011; 54: 1298-1303. doi: 10.1007/s00125-010-2040

Yеlgina SI, Ushakova GA. THE Functioning (hormone indexes) of the Newborn girls’ reproductive system in full-term (physiological) and preterm pregnancy. In: Klinicheskie i fundamental'nye aspekty reproduktivnykh problem i zdorov'ya zhenshchiny. Materialy XV mezhdunarodnoy nauchno-prakticheskoy konferentsii. 21-22 aprelya 2011 g. Kemerovo: Meditsina i Prosveshchenie, 2011. Russian (Елгина С.И., Ушакова Г.А. Функциональное состояние репродуктивной системы новорожденных девочек при доношенной и недоношенной беременности. В сб.: Клинические и фундаментальные аспекты репродуктивных проблем и здоровья женщины. Матер. XV междунар. науч.-практ. конф., 21-22 апреля 2011 г. Кемерово: Медицина и Просвещение, 2011)

Yelgina SI, Ushakova GA, Nikulina EN. Reproductive system in full-term and preterm newborn girls. Fundamental and Clinical Medicine. 2016; 1(3): 39-45. Russian (Елгина С.И., Ушакова Г.А., Никулина Е.Н. Оценка репродуктивной системы и состояния овариального резерва у доношенных и недоношенных новорожденных девочек //Фундаментальная и клиническая медицина. 2016. Т. 1, № 3. С. 39-45)

Magee LA, CHIPS Study Group; von Dadelszen P, Singer J, Lee T, Rey E, Ross S et al. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In pregnancy study (CHIPS) trial. BJOG. 2016; 123(7): 1143-1151. doi: 10.1111/1471-0528.13569

Chung JH, Melsop KA, Gilbert WM, Caughey AB, Walker CK, Main EK. Increasing pre-pregnancy body mass index is predictive of a progressive escalation in adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2012; 0: 1-23

Johansson K, Cnattingius S, Näslund I, Roos N, Trolle Lagerros Y, Granath F, et al. Outcomes of pregnancy after bariatric surgery. N Engl J Med. 2015; 372(9): 814-824. doi: 10.1056/NEJMoa1405789

Middelbeek RJ, James-Todd T, Cavallerano JD, Schlossman DK, Patti ME, Brown FM. Gastric bypass surgery in severely obese women with type 1 diabetes: anthropometric and cardiometabolic effects at 1 and 5 years postsurgery. Diabetes Care. 2015; 38(7): e104-105. doi: 10.2337/dc15-0396

Duntas LH, Orgiazzi J, Brabant G. The Interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011; 75(1): 1-9. doi: 10.1111/j.1365-2265.2011.04029.x

Catalano PM, Hauguel-De MS. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011; 204: 479-487. doi: 10.1016/j.ajog.2010.11.039

Elgina SI, Nikulina EN. Predicting a decrease in ovarian reserve in adolescent girls. Mother and Baby in Kuzbass. 2020; 1: 23-31. Russian (Елгина С.И., Никулина Е.Н. Прогнозирование снижения овариального резерва у девушек-подростков //Мать и Дитя в Кузбассе. 2020. № 1. С. 23-31)

Lindsay RS, Nelson SM, Walker JD, et al. Programming of adiposity in offspring of mothers with type 1 diabetes at age 7 years. Diabetes Care. 2010; 33: 1080-1085. doi: 10.2337/dc09-1766

American Diabetes Association Management of diabetes in pregnancy. Sec. 12. In standards of medical care in diabetes 2016. Diabetes Care. 2016; 39(1): S94-S98

Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes. Diabetes Care. 2013; 36(7): 1877-1883. doi: 10.2337/dc12-2360

Law GR, Ellison GT, Secher A, et al. Analysis of continuous glucose monitoring in pregnant women with diabetes: disting temportal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care. 2015; 38: 1319-1324. doi: 10.2337/dc15-0070

Garcia-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010; 53: 446-451. doi: 10.1007/s00125-009-1633-z

Callesen NF, Ringholm L, Stage E, Damm P, Mathiesen ER. Insulin requirements in type 1 diabetic pregnancy: Do twin pregnant women require twice as much insulin as singleton pregnant women? Diabetes Care. 2012; 35: 1246-1248. doi: 10.2337/dc11-2467

Zisser HC, Biersmith MA, Jovanovic LB, Yogev Y, Hod M, Kovatchev BP. Fetal risk assessment in pregnancies complicated by diabetes mellitus. J Diabetes Sci Technol. 2010; 4: 1368-1373. doi: 10.1177/193229681000400610

Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014; 6: 2

Huang T, Brown FM, Curran A, James-Todd T. Association of pre-pregnancy BMI and postpartum weight retention with postpartum HbA1c among women with Type 1 diabetes. Diabet Med. 2015; 32(2): 181-188. doi: 10.1111/dme.12617

Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015; 372(5): 407-417. doi: 10.1056/NEJMoa1404595

Вeglova AYu, Elgina SI. Diagnostics of PCOS based on clinical and anamnestic factors, laboratory and ultrasound markers using a computer program. Obstetrics and Gynecology. 2020; 2: 133-140. Russian (Беглова А.Ю., Елгина С.И. Диагностика СПКЯ на основе клинико-анамнестических факторов, лабораторных и ультразвуковых маркеров с применением компьютерной программы //Акушерство и гинекология. 2020. № 2. С. 133-140)

Rothberger S, Carr D, Brateng D, Hebert M, Easterling TR. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens. 2010; 23: 1234-1240. doi: 10.1038/ajh.2010.159

Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG. 2014; 121(10): 1210-1218. doi: 10.1111/1471-0528.12737

Roseboom TJ, Ravelli AC, van der Post JA, Painter RC. Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2011; 156: 56-59. doi: 10.1016/j.ejogrb.2011.01.010

Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014; 123(6): 1272-1279. doi: 10.1097/AOG.0000000000000242

Koren G. Treating morning sickness in the United States changes in prescribing are needed. Am J Obstet Gynecol. 2014; 211(6): 602-606. doi: 10.1016/j.ajog.2014.08.017

Pignone M, Alberts MJ, Colwell JA, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the american diabetes association, a scientific statement of the american heart association, and an expert consensus document of the american college of cardiology foundation. Diabetes Care. 2010; 33: 1395-1402. doi: 10.2337/dc10-0555

Taguchi N, Rubin ET, Hosokawa A, et al. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. Reprod Toxicol. 2008; 26: 175-177. doi: 10.1016/j.reprotox.2008.06.009

Pacheco LD, Saade GR, Hankins G. Acute myocardial infarction during pregnancy. Clin Obstet Gynecol. 2014; 57(4): 835-843. doi: 10.1097/GRF.0000000000000065

De Groot LD, Abalovich M, Alexander EK, Azizi F, Mestman J, Negro R et al. Management of thyroid dysfunction during pregnancy and the postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97(8): 2543-2565. doi: 10.1210/jc.2011-2803

Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid. 2011; 21(10): 1081-1125. doi: 10.1089/thy.2011.0087

Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists. Endocr Pract. 2011; 17: 456-520. doi: 10.4158/EP.17.3.456

Wojcicki JM, Heyman MB. Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression. J Matern Fetal Neonatal Med. 2011; 24: 680-686. doi: 10.3109/14767058.2010.521873

Persson M, Pasupathy D, Hanson U, Norman M. Birth size distribution in 3,705 infants born to mothers with type 1 diabetes: a population-based study. Diabetes Care. 2011; 34: 1145-1149. doi: 10.2337/dc10-2406

Al-Agha R, Firth RG, Byrne M, Murray S, Daly S, Foley M, et al. Outcome of pregnancy in type 1 diabetes mellitus (T1DMP): results from combined diabetes-obstetrical clinics in Dublin in three university teaching hospitals (1995-2006). Ir J Med Sci. 2012; 181(1): 105-109. doi: 10.1007/s11845-011-0781-6

Aman J, Hansson U, Ostlund I, Wall K, Persson B. Increased fat mass and cardiac septal hypertrophy in newborn infants of mothers with well-controlled diabetes during pregnancy. Neonatology. 2011; 100: 147-154. doi: 10.1159/000323741

Mulder EJ, Koopman CM, Vermunt JK, de Valk HW, Visser GH. Fetal growth trajectories in Type-1 diabetic pregnancy. Ultrasound Obstet Gynecol. 2010; 36: 735-742. doi: 10.1002/uog.7700

Maresh M, Holmes VA, Patterson CP. Diabetes and Pre-eclampsia Intervention Trial Study Goup et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015; 38: 34-42. doi: 10.2337/dc14-1755

Clinical recommendations: Gestational diabetes. Russian Association of Endocrinologists, Russian Association of Obstetricians and Gynecologists, 2016. Russian (Гестационный сахарный диабет: Клинические рекомендации. Российская ассоциация эндокринологов, Российская ассоциация акушеров-гинекологов, 2016)

Murphy HR, Steel SA, Roland JM, et al. Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med. 2011; 28: 1060-1067. doi: 10.1111/j.1464-5491.2011.03333.x

Knip M, Åkerblom HK, Becker D, et al. TRIGR Study Group. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA. 2014; 311(22): 2279-2287. doi: 10.1001/jama.2014.5610

Hawdon JM. Babies born after diabetes in pregnancy: what are the short- and long-term risks and how can we minimise them? Best Pract Res Clin Obstet Gynaecol. 2011; 25: 91-104. doi: 10.1016/j.bpobgyn.2010.10.005

Mahmood I, Jamal M, Khan N. Effect of mother-infant early skin-to-skin contact on breastfeeding status: a randomized controlled trial. J Coll Physicians Surg Pak. 2011; 21: 601-605. doi: 10.2011/JCPSP.601605


Статистика просмотров

Загрузка метрик ...

Ссылки

  • На текущий момент ссылки отсутствуют.